NCT Number: NCT00356564
Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
Persistence of seroprotective antibody concentrations & immunological memory shown by the ability to mount a response to a challenge dose of HBV vaccine
Looking for future studies?
Notify MeKey information
Conditions
Age range
7 year–9 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
GSK Investigational Site, Ettenheim, Baden-Wurttemberg, Germany
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- A male or female aged 7 to 9 years at the time of study entry .
- Subjects who have received a total of 4 doses of DTPa-HBV-IPV/Hib vaccine or a total of 4 doses of HBV vaccine in previous vaccination studies.
- Evidence of previous hepatitis B booster vaccination or disease since administration of the fourth dose of DTPa-HBV-IPV/Hib or HBV vaccine.
Treatment and study plan
Primary outcomes
-
Anti-HBs antibody concentration
Secondary outcomes
-
Persistence of antibodies to the other DTPa-HBV-IPV/Hib vaccine antigens.
-
Sol & unsol symptoms after HBV vaccination, SAEs
Sponsors and collaborators
Lead sponsor
GlaxoSmithKline
Industry
Registry information
Official study title
Multicentre Study to Assess Persistence of Antibodies Against Hepatitis B and Immune Response to a Hepatitis B Challenge Dose in Healthy Children 7 to 9 Years Old Previously Vaccinated With 4 Doses of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine
Important dates
- Study start
- 2006
- Study completion
- 2006
- First posted
- Jul 26, 2006
- Registry last updated
- Oct 12, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
NCT00004850
Blood-Borne Infections, Communicable Diseases
Bethesda, Maryland, United States
View Trial DetailsStudy to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series
NCT05457946
Actinomycetales Infections, Bacterial Infections
Seoul, South Korea
View Trial DetailsComparing Hepatitis B Vaccination Schedules in Patients on Hemodialysis
NCT07784452
Blood-Borne Infections, Bronchial Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsStudy to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
NCT06422767
Blood-Borne Infections, Communicable Diseases
Austin, Texas, United States
View Trial Details